Edition:
United States

Check Cap Ltd (CHEK.OQ)

CHEK.OQ on NASDAQ Stock Exchange Capital Market

0.88USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,538
52-wk High
$2.60
52-wk Low
$0.81

Chart for

About

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company's system consists of main components, such as ingestible... (more)

Overall

Beta: --
Market Cap(Mil.): $15.03
Shares Outstanding(Mil.): 16.99
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.07 15.47
EPS (TTM): -- -- --
ROI: -- 15.07 33.71
ROE: -- 16.57 16.38

BRIEF-Check-Cap Announces Advancement In GE Healthcare Manufacturing Collaboration

* CHECK-CAP ANNOUNCES ADVANCEMENT IN GE HEALTHCARE MANUFACTURING COLLABORATION

Dec 05 2017

BRIEF-Armistice Capital LLC Reports A 5.5 Pct Passive Stake In Check Cap Ltd As Of Nov 20

* ARMISTICE CAPITAL, LLC REPORTS A 5.5 PERCENT PASSIVE STAKE IN CHECK CAP LTD AS OF NOVEMBER 20, 2017 - SEC FILING Source text: [http://bit.ly/2i4d1YH] Further company coverage:

Nov 30 2017

BRIEF-Check-Cap announces $2.5 million registered direct offering

* Check-Cap Ltd. announces $2.5 million registered direct offering

Nov 20 2017

BRIEF-Check-Cap reports qtrly loss per share $0.13​

* Check Cap Ltd qtrly loss per share $0.13​ Source text for Eikon: Further company coverage:

Nov 06 2017

Earnings vs. Estimates